Juergens S
Department of Psychiatry and Psychology, Virginia Mason Clinic, Seattle, Washington 98111.
J Subst Abuse Treat. 1991;8(1-2):43-51. doi: 10.1016/0740-5472(91)90026-7.
Alprazolam and diazepam, the two most prescribed benzodiazepine anxiolytics in the United States, have potential for addictive use. The Drug Abuse Warning Network (DAWN) indicates they are the most mentioned benzodiazepines, and the National Household Survey indicates significant abuse of tranquilizers. Both drugs are rapidly absorbed and enter the brain tissue rapidly, leading to reinforcement. Alprazolam has a shorter half-life, which may lead to more withdrawal symptoms than diazepam. In experimental conditions, they are among the most reinforcing benzodiazepines. Each causes a withdrawal syndrome, but alprazolam withdrawal may be more severe and may occur after a shorter period of use. Adverse effects from their use are said to be rare, yet subtle negative consequences may be seen with some regularity. Alprazolam deserves special caution because of its relative newness, great popularity, reinforcing capabilities, relatively severe withdrawal syndrome, and reports of addiction and negative consequences of use.
在美国,阿普唑仑和地西泮是两种最常被处方的苯二氮䓬类抗焦虑药,存在成瘾性使用的可能性。药物滥用警示网络(DAWN)表明它们是被提及最多的苯二氮䓬类药物,而全国家庭调查显示镇静剂存在大量滥用情况。这两种药物都能迅速被吸收并快速进入脑组织,从而导致强化作用。阿普唑仑的半衰期较短,这可能导致比地西泮更多的戒断症状。在实验条件下,它们是强化作用最强的苯二氮䓬类药物之一。每种药物都会引发戒断综合征,但阿普唑仑戒断可能更严重,且可能在较短的使用期后就会出现。据说它们使用的不良反应很少见,但仍可能会经常出现一些细微的负面后果。由于阿普唑仑相对较新、广受欢迎、强化能力强、戒断综合征相对严重,以及有关于成瘾和使用负面后果的报道,因此值得特别谨慎对待。